Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Amryt Pharma plc
  6. Calendar
    AMYT   GB00BKLTQ412

AMRYT PHARMA PLC

(AMYT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on AMRYT PHARMA PLC
06/10/21 Q3 2021 Earnings Release (Projected)
06/24/21 Annual General Meeting
09/14/21 Interim 2021 Earnings Release (Projected)
04/20/22 FY 2021 Earnings Release (Projected)
Past events on AMRYT PHARMA PLC
05/05/21 | 08:30am Q1 2021 Earnings Call
05/05/21 | 07:00am Q1 2021 Earnings Release
03/25/21 | 06:00am Benzinga BiotechSmall Cap Conference
03/04/21 | 08:30am FY 2020 Earnings Call
Upcoming sector events for AMRYT PHARMA PLC
05/15/21 AMGEN INC. : American College of Cardiology Scientific Meeting - Poster Session 2118
05/15/21 AMGEN INC. : American College of Cardiology Scientific Meeting - Poster Session 1056-05
05/15/21 AMGEN INC. : American College of Cardiology Scientific Meeting - Poster Session 910-08
05/15/21 AMGEN INC. : American College of Cardiology Scientific Meeting - Poster Session 2108
More events
Past sector events for AMRYT PHARMA PLC
05/14/21 | 01:00pm BIOMARIN PHARMACEUTICAL INC. : American Society of Gene and Cell Therapy Virtual Meeting - Cheng Su
05/14/21 TEVA PHARMACEUTICAL INDUSTRIES LIMITED : American Thoracic Society International Conference - Abstract No - A2259
05/14/21 TEVA PHARMACEUTICAL INDUSTRIES LIMITED : American Thoracic Society International Conference - Abstract No - A1459
05/14/21 SK BIOSCIENCE CO.,LTD. : Q1 2021 Earnings Release
Annual publications
Annual results2018201920202021 (e)
Sales
M $
Released
Forecast
Spread
16,3

58,1
30,5
91%
183
181
0,64%

208
Operating income
(EBITDA)
M $
Released
Forecast
Spread


2,96
-7,70
138%
30,4
30,2
0,66%

24,6
Operating profit
(EBIT)
M $
Released
Forecast
Spread


-9,70
-7,70
-26%
-46,5
-44,4
-4,6%

-28,1
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread




-106
-88,7
-19%

-62,3
Net income
M $
Released
Forecast
Spread


-65,5

-105
-80,3
-30%

-60,7
EPS
$
Released
Forecast
Spread


-0,86

-0,66
-0,56
-17%

-0,26
Announcement Date04/17/201905/11/202003/04/2021

Quarterly publications
Previous periodNext period
Quarterly results2020 Q12020 Q22020 Q32020 Q42021 Q12021 Q2 (e)
Sales
M $
Released
Forecast
Spread


46,2
40,6
14%
49,3
37,0
33%
42,5
41,5
2,6%
48,4
45,0
7,6%

51,5
Operating income
(EBITDA)
M $
Released
Forecast
Spread


6,90
2,20
214%
13,5
0,70
1 829%
5,40
5,65
-4,4%
9,90
6,05
64%

6,65
Operating profit
(EBIT)
M $
Released
Forecast
Spread


-12,0
-16,1
26%
-3,61
-16,3
78%
-13,9
-9,10
-53%
-3,39
-9,30
64%

-4,45
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


-21,3
-24,0
11%
-8,65
-24,1
64%
-45,2
-20,4
-121%
-15,9
-13,9
-15%

-13,9
Net income
M $
Released
Forecast
Spread
-28,9

-18,2
-22,1
18%
-10,5
-22,5
53%
-47,0
-20,4
-130%
-16,5
-13,9
-19%

-13,9
EPS
$
Released
Forecast
Spread
-0,19



-0,07
-0,17
59%






Announcement Date05/11/202008/06/202011/05/202003/04/202105/05/2021

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise